Passage Bio, Inc. (NASDAQ:PASG) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Maxine Gowen Other companies: Aclaris Therapeutics, Inc. (Director · Since at least Jul 2, 2019); Trevena, Inc. (Director · Since at least Jan 30, 2014); Aceragen Inc. (Director · Jan 4, 2015 – Aug 10, 2023 · Past); Akebia Therapeutics, Inc. (Director · Jul 28, 2014 – Jun 5, 2020 · Past); Human Genome Sciences Inc (Director · Feb 15, 2008 – Jul 30, 2012 · Past) | Chairwoman · Since at least Feb 18, 2021 |
| Jill Quigley Other companies: Chemomab Therapeutics Ltd. (Board Director · Since at least Jun 16, 2022); Terns Pharmaceuticals, Inc. (Director · Since at least Feb 4, 2021) | Chief Operating Officer · Feb 27, 2020 – Dec 8, 2021 · Past |
| Saqib Islam Other companies: SpringWorks Therapeutics Inc (Chief Executive Officer, Director · Since at least Jan 7, 2021); ARS Pharmaceuticals, Inc. (Director · Since at least Dec 3, 2020) | Director · Since at least May 27, 2021 |
| Derrell D. Porter Other companies: Acumen Pharmaceuticals, Inc. (CEO: cTRL Therapeutics, Inc. · Since at least Jan 4, 2023) | Director · Since at least May 27, 2021 |
| Mark S Forman Other companies: Ventyx Biosciences Inc (Chief Medical Officer · Since at least Aug 12, 2024) | CHIEF MEDICAL OFFICER · Mar 30, 2022 – Mar 15, 2024 · Past |
| Monika Maria Toernsen Other companies: Immunic, Inc. (Director · Since at least Jul 5, 2022) | Chief Commercial Officer · Jul 19, 2021 – Sep 15, 2022 · Past |
| Thomas Kassberg Other companies: Ultragenyx Pharmaceutical Inc. (CBO & EVP · Oct 23, 2023 – Mar 1, 2025 · Past) | Chief Business Officer and Executive Vice President of Ultragenyx Pharmaceutical Inc. · Since at least Sep 10, 2024 |
| Athena Countouriotis | Chief Executive Officer and Chairperson of the board of directors of Avenzo Therapeutics · Since at least Nov 5, 2026 |
| Bruce A Goldsmith | CEO and President, Director · Feb 27, 2020 – May 27, 2022 · Past |
| Dolan Sondhi | Director · Since at least Jul 27, 2023 |
| Edgar B Cale | GC & CORPORATE SECRETARY · Feb 27, 2020 – Mar 15, 2025 · Past |
| Eliseo Oreste Salinas | Chief Res. & Develop Officer · Mar 22, 2021 – Feb 10, 2022 · Past |
| Sandip Kapadia | Chief Financial Officer of Harmony Biosciences Holdings, Inc. · Since at least Nov 5, 2026 |
| William Chou | President and Chief Executive Officer · Since at least Nov 5, 2026 |